
Brenda Libby Coleman
Examiner (ID: 16325)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3882791
[patent_doc_number] => 05798359
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Piperazino derivatives as neurokinin antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/451113
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15905
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798359.pdf
[firstpage_image] =>[orig_patent_app_number] => 451113
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451113 | Piperazino derivatives as neurokinin antagonists | May 24, 1995 | Issued |
Array
(
[id] => 3695633
[patent_doc_number] => 05618815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => '1,9-bridged thiazolo[3,2-a]quinoline derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/444246
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5777
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618815.pdf
[firstpage_image] =>[orig_patent_app_number] => 444246
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444246 | 1,9-bridged thiazolo[3,2-a]quinoline derivatives | May 18, 1995 | Issued |
Array
(
[id] => 3604716
[patent_doc_number] => 05578720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-26
[patent_title] => 'Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/444124
[patent_app_country] => US
[patent_app_date] => 1995-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3567
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/578/05578720.pdf
[firstpage_image] =>[orig_patent_app_number] => 444124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444124 | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof | May 17, 1995 | Issued |
Array
(
[id] => 3848714
[patent_doc_number] => 05719156
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Piperazino derivatives as neurokinin antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/432739
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15826
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/719/05719156.pdf
[firstpage_image] =>[orig_patent_app_number] => 432739
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432739 | Piperazino derivatives as neurokinin antagonists | May 1, 1995 | Issued |
Array
(
[id] => 3833284
[patent_doc_number] => 05712274
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => 'Thienotriazolodiazepine compounds and their pharmaceutical use'
[patent_app_type] => 1
[patent_app_number] => 8/413444
[patent_app_country] => US
[patent_app_date] => 1995-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30163
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 498
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712274.pdf
[firstpage_image] =>[orig_patent_app_number] => 413444
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/413444 | Thienotriazolodiazepine compounds and their pharmaceutical use | Mar 29, 1995 | Issued |
Array
(
[id] => 3805986
[patent_doc_number] => 05830888
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Macrocyclic retroviral protease inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/406614
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7655
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 675
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830888.pdf
[firstpage_image] =>[orig_patent_app_number] => 406614
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/406614 | Macrocyclic retroviral protease inhibitors | Mar 19, 1995 | Issued |
| 08/401049 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | Mar 7, 1995 | Abandoned |
Array
(
[id] => 3840372
[patent_doc_number] => 05744496
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/359860
[patent_app_country] => US
[patent_app_date] => 1994-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5621
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744496.pdf
[firstpage_image] =>[orig_patent_app_number] => 359860
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/359860 | Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors | Dec 19, 1994 | Issued |
Array
(
[id] => 3831097
[patent_doc_number] => 05760221
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Method for the preparation of hexahydroazepinones and hexahydroazepinoles'
[patent_app_type] => 1
[patent_app_number] => 8/359457
[patent_app_country] => US
[patent_app_date] => 1994-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3411
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 245
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/760/05760221.pdf
[firstpage_image] =>[orig_patent_app_number] => 359457
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/359457 | Method for the preparation of hexahydroazepinones and hexahydroazepinoles | Dec 18, 1994 | Issued |
Array
(
[id] => 3695471
[patent_doc_number] => 05618803
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-08
[patent_title] => 'Targeted drug delivery via phosphonate derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/340896
[patent_app_country] => US
[patent_app_date] => 1994-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20730
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/618/05618803.pdf
[firstpage_image] =>[orig_patent_app_number] => 340896
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/340896 | Targeted drug delivery via phosphonate derivatives | Nov 14, 1994 | Issued |
Array
(
[id] => 4220256
[patent_doc_number] => 06040308
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Chroman derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/330957
[patent_app_country] => US
[patent_app_date] => 1994-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23173
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040308.pdf
[firstpage_image] =>[orig_patent_app_number] => 330957
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/330957 | Chroman derivatives | Oct 27, 1994 | Issued |
Array
(
[id] => 4358637
[patent_doc_number] => 06201119
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-13
[patent_title] => 'Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones'
[patent_app_type] => 1
[patent_app_number] => 8/304951
[patent_app_country] => US
[patent_app_date] => 1994-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22980
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/201/06201119.pdf
[firstpage_image] =>[orig_patent_app_number] => 304951
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/304951 | Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones | Oct 16, 1994 | Issued |